Also in our study, metformin decreased TNFα production in the samples of all patients; however, reduced levels of IL-1β and IL-6 were observed exclusively in blood cultures derived from obese patients with NAFLD and MetS. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.